BioCardia, Inc. (BCDA)

NASDAQ: BCDA · IEX Real-Time Price · USD
+0.030 (6.59%)
Feb 26, 2024, 12:13 PM EST - Market open

BioCardia Revenue

BioCardia had revenue of $570.00K in the twelve months ending September 30, 2023, down -56.98% year-over-year. Revenue in the quarter ending September 30, 2023 was $357.00K with 68.40% year-over-year growth. In the year 2022, BioCardia had annual revenue of $1.35M with 33.20% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
11.64M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 20221.35M337.00K33.20%
Dec 31, 20211.02M870.00K600.00%
Dec 31, 2020145.00K-565.00K-79.58%
Dec 31, 2019710.00K85.00K13.60%
Dec 31, 2018625.00K146.00K30.48%
Dec 31, 2017479.00K-97.00K-16.84%
Dec 31, 2016576.00K-328.00K-36.28%
Dec 31, 2015904.00K477.00K111.71%
Dec 31, 2014427.00K159.00K59.33%
Dec 31, 2013268.00K206.00K332.26%
Dec 31, 201262.00K50.00K416.67%
Dec 31, 201112.00K--
Dec 31, 20100--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Zhongchao 17.23M
Biotricity 11.63M
Syra Health 5.71M
Benitec Biopharma 61.00K
Bionomics 15.21K
Revenue Rankings